cbdMD Inc
YCBD
查看详细走势图
0.923USD
-0.021-2.21%
收盘 02/06, 16:00（美东）报价延迟15分钟
8.23M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-2.21%
5天
-11.26%
1月
-19.75%
6月
+7.60%
今年开始到现在
-31.64%
1年
-79.61%
查看详细走势图
TradingKey cbdMD Inc股票评分
单位: USD 更新时间: 2026-02-06操作建议
cbdMD Inc当前公司基本面数据相对健康，最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理，在药品行业排名103/159位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价2.00。中期看，股价处于上升通道。近一个月，市场表现较差，但基本面评分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
cbdMD Inc评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
cbdMD Inc亮点
亮点风险
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
业绩增长期
公司处于发展阶段，最新年度总收入19.19M美元
估值合理
公司最新PE估值-0.85，处于3年历史合理位
先锋集团持仓
明星投资者先锋集团持仓，最新持仓市值98.21K
活跃度增加
近期活跃度增加，过去20天平均换手率-0.27
分析师目标
根据
1
位分析师
买入
评级
2.000
目标均价
+111.91%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
cbdMD Inc新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
cbdMD Inc简介
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
公司代码YCBD
公司cbdMD Inc
CEOKennedy (T. Ronan)
网址https://www.cbdmd.com/
相关品种
